Our previous study demonstrated that intermittent administration of PTH enhances primary stability in low bone density sites in rabbits with glucocorticoid-induced osteoporosis [14] and evaluated the effects of intermittent continual administration of PTH on bone formation around the implant in a rabbit model of osteoporosis [15]. The gene discussed is PTH; the disease is osteoporosis.